
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is a United States-based company in the Healthcare sector with a market capitalisation of $9.6B. Its FinScore is 53/100; its highest-scoring layer is Momentum (90) and its lowest is Growth (28). The shares trade at 43.1x trailing earnings and are up 17% year to date.
Share price performance
About Bio-Rad Laboratories, Inc.
www.bio-rad.comBio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics. The Life Science division develops and provides a comprehensive array of reagents, laboratory apparatus, and instruments. These are vital for various applications, including scientific research methodologies, biopharmaceutical production processes, and food quality testing. This segment dedicates its efforts to key areas within the life sciences, such as proteomics, genomics, biopharmaceutical development, cellular biology, and ensuring food safety. Its diverse clientele includes academic institutions (universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology researchers, and both food producers and testing laboratories. Conversely, the Clinical Diagnostics division specializes in designing, producing, selling, and supporting diagnostic test systems, informatics solutions, test kits, and specific quality control measures for clinical laboratories. This segment furnishes reagents, instrumentation, and software precisely tailored to address particular requirements within the in vitro diagnostics market. Its products are utilized by reference laboratories, hospital labs, state-operated newborn screening facilities, physicians' private offices, and blood transfusion centers. Furthermore, Bio-Rad offers systems and products designed for separating intricate chemical and biological substances, as well as for identifying, analyzing, and purifying their individual components. The company distributes its offerings through a multi-channel approach, leveraging both its direct sales force and a network of distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was established in 1952 and its corporate headquarters are located in Hercules, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- HQ
- United States
- Fiscal year-end
- December
- Trading currency
- USD
- Reporting currency
- USD
- Fundamentals updated
- 9 days ago
- Market cap
- $9.6B
- Shares outstanding
- 26.7M
- P/E (TTM)
- 43.1x
- Beta (issuer)
- 1.11
- Revenue (latest FY)
- $2.6B
Revenue breakdown
- Clinical Diagnostics60.5%$1.6B
- Life Science39.5%$1.0B
FinScore
As of 2026-10-19Snapshot
Ownership
As of 2026-03-31Sign up or log in to see Analysis
Analysis for Bio-Rad Laboratories, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Bio-Rad Laboratories, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Bio-Rad Laboratories, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Bio-Rad Laboratories, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Bio-Rad Laboratories, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Bio-Rad Laboratories, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.